Mohnark Pharmaceuticals Inc. 2022-06-30 Health safe CPSC
Health · CPSC · Recall #CPSC-22754
Lidocaine 4% Topical Anesthetic Cream Recall
Issued June 30, 2022 · Mohnark Pharmaceuticals Inc. · 9,000 units affected
In June 2022, Mohnark Pharmaceuticals Inc. recalled the Lidocaine 4% Topical Anesthetic Cream, a low-risk health recall reported by the CPSC.
Compiled by Maya Ellison, RecallCheckr
What this means for you
The product contains lidocaine which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging is not child resistant, posing a risk of poisoning to young children if they ingest the anesthetic cream.
What you should do
- 1 Stop using Lidocaine 4% Topical Anesthetic Cream right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Mohnark Pharmaceuticals Inc. to arrange your refund. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Refund): Consumers should immediately stop using the recalled cream and store it in a location out of sight and reach of children. Contact Mohnark Pharmaceuticals for instructions on how to dispose of the product to receive a full refund. Mohnark Pharmaceuticals is contacting all known purchasers directly.
Recall details
- Brand
- Mohnark Pharmaceuticals Inc.
- Category
- Health
- Recall date
- June 30, 2022
- Units affected
- 9,000
- Sold at
- Online at Amazon.com and Walmart.com from January 2021 through January 2022 for about $7.
- Recall number
- CPSC-22754
- Made in
- United States
- Issuing agency
- CPSC
In context
- Mohnark Pharmaceuticals Inc. has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- 9,000 units is enough to reach roughly 1 in every 14,556 US households.
- This is the 870th Health recall we've logged in 2022.